Adherium (ASX: ADR) is showing strong commercial momentum with its Hailie® Smartinhaler® and cloud-based platform, as Remote Patient Monitoring (RPM) revenue, device shipments, and patient activations continue to climb. This growth reflects the scalability of Adherium’s digital respiratory care platform.

🩺 RPM revenue is growing quickly, with its February 2026 figure up 51% on that for December 2025 to February 2026; combined January/February 2026 RPM revenue has already surpassed that for the Dec-25 quarter.
🚀 Adherium’s cumulative RPM shipments were up 43% and activations up 53% between end-December 2025 and end-February 2026, underscoring the strength of Adherium’s commercial model.
🌎 Adherium’s patient pipeline continues to expand, with access to roughly 48,000 insurance verified asthma patients via its call centre and partners including Allergy Partners, supporting its target of 10,000 RPM patients by the end of 2026.

Adherium Chief Executive Officer Dawn Bitz commented:
“ Through our collaboration with Allergy Partners, we`ve built a major platform for growth - clinicians want patients to have our technology and patients are benefitting significantly from improved respiratory outcomes. With the benefit of these initiatives and reimbursement tailwinds, we have strong confidence in delivering our previously announced target of 10,000 RPM patients by the end of 2026.”

Emmerson Resources (ASX:ERM) is acquiring Pan African Resources in a transaction valued at approximately A$311 million. The deal provides shareholders with an immediate value realisation event and continued exposure to a cash-generating gold producer.

⛏️ This acquisition adds scale and production capacity, giving ERM access to a broader portfolio of gold assets and a more resilient revenue base.
🏭 Shareholders gain exposure to steady cash generating operations, supporting investment in future projects and accelerating development across key assets.
🌏 The merger strengthens Emmerson Resources’ strategic presence in the Tennant Creek region, and creates a platform for potential growth and value creation in the broader gold sector.

Emmerson Resources Chairman Mark Connelly commented:
“The transaction delivers our shareholders with an immediate value realisation event at an attractive premium, whilst providing exposure to a larger, more diversified and well-capitalised gold producer with a broad portfolio and a strengthened platform for long-term value creation.”

Dimerix (ASX:DXB) has successfully concluded the ACTION3 Phase 3 trial of DMX-200 in focal segmental glomerulosclerosis (FSGS), completing recruitment beyond the targeted 286 adults. The study is on track to deliver full 2-year data in March 2028. The milestone strengthens the statistical power of the trial and positions Dimerix for future regulatory submission and commercialisation.

💉 ACTION3 Phase 3 has now dosed 333 adult patients, exceeding the original target due to patients already in screening being allowed to progress. This strengthens the study’s ability to detect treatment effects.
⏳ A 2-year study, evaluating DMX-200 remains on track for completion in March 2028, generating robust data on proteinuria reduction and kidney function.
🚀 Achieving this milestone de-risks the study, positioning Dimerix to advance toward regulatory submission, potential approval, and commercialisation while maintaining focus on licensing opportunities.

Dimerix Managing Director Nina Webster commented:
“I am delighted with the achievement of such a significant milestone in the Company’s clinical development of DMX-200 in FSGS patients. Dimerix and our current commercial partners are well positioned to continue to advance toward regulatory submission and potential approval and commercialisation of DMX-200. We are sincerely grateful to the patients and their families for their vital contribution to this important program."

Far East Gold (ASX:FEG) is advancing its flagship Idenburg Gold Project in Papua, Indonesia, where recent extension drilling at the Sua prospect has confirmed high-grade gold mineralisation extending both down dip and along strike. Managing Director and CEO Shane Menere joins The Stock Network’s Lel Smits to discuss the latest drilling success, the upcoming resource update and how the next phase of drilling could further grow the Idenburg gold system.

⛏️ High-grade extensions confirm scale potential at Sua
🚧 JORC resource update pending
🗺️ Next phase of resource expansion drilling

Tetratherix (ASX:TTX) is progressing a portfolio of regenerative medicine technologies built on its proprietary Tetramatrix™ platform, designed to support bone regeneration, tissue spacing and tissue healing across multiple surgical applications. With several products moving through clinical validation and regulatory pathways, Tetratherix is approaching an important transition from a research-focused organisation toward commercial scale. Key developments include global dental distribution progress, advancing FDA pathways across multiple programs and new partnerships with leading medical technology companies. CEO Will Knox joins The Stock Network’s Lel Smits to discuss the Company’s development milestones, the strategy behind its multi-product platform and what the next phase of growth could look like as Tetratherix moves toward commercialisation.

🧬 Advancing a multi-product regenerative medicine platform
🤝 Strategic partnerships and regulatory progress
🎯 A disciplined pathway toward commercial scale

Dateline Resources (ASX: DTR, OTCQB: DTREF, FSE: YE1) has significantly expanded its Music Valley Heavy Rare Earth (HREE) Project in California, establishing a district-scale landholding and advancing exploration across the prospective Pinto Gneiss unit.

🌎 19,380 acres staked: Dateline added 969 new claims after confirmation from the Bureau of Land Management (BLM).
📍 District-scale project: Music Valley now spans 20,520 acres across 1,026 claims, including nearly 9km of the prospective Pinto Gneiss unit.
🛰️ Exploration underway: Airborne magnetics and radiometric survey now around 65% complete, with geological mapping and surface sampling already in progress.

“Music Valley provides Dateline with district-scale exposure to a geological unit where heavy rare earth mineralisation was first documented by USGS geologists more than seventy years ago. Our approach is to build on that historical work using modern exploration techniques. Airborne geophysics, detailed mapping and systematic sampling are already underway, allowing us to quickly generate and prioritise drill targets across the consolidated land position.” - Stephen Baghdadi, Dateline Resources Managing Director

ASX announcement ⚡ https://announcements.asx.com.au/asxpdf/20260311/pdf/06x8xd8vhx8crm.pdf

Rox Resources (ASX:RXL) has secured A$350 million in committed debt facilities which will fully fund the development of its 100%-owned Youanmi Gold Project in Western Australia, advancing the project towards production.

🏗️ With full funding now in place, Rox Resources can move confidently to a Final Investment Decision in March 2026 and begin construction, unlocking the project’s potential as a high-margin gold producer.
⛏️ The A$350 million financing package ensures Youanmi’s development is fully de-risked, giving Rox Resources the certainty needed to progress without reliance on further capital.
🪙 The package includes a A$300M Senior Secured Project Term Loan, A$20M Cost Overrun Facility, and A$30M Bank Guarantee Facility from a syndicate of tier-one banks, providing both scale and financial security for the project.

Rox Resources Managing Director & Chief Executive Officer Phillip Wilding commented:
“The commitment of debt funding from an impressive selection of Australian and International banks is yet another major milestone for Rox as we accelerate our pathway to production for the Youanmi Gold Project.”
“The project is now fully funded through to production, and we look forward to making a Final Investment Decision later in this quarter, before commencing construction activities.”

Aerometrex (ASX:AMX) has secured multiple government contracts across federal, state, and local departments, providing increased revenue visibility and strengthening its government customer base. The contracts highlight AMX’s established onshore delivery, sovereign capability, and trusted status as an Australian-owned business.

🛰️ AMX has won multiple government contracts covering MetroMap subscriptions reinforcing its recurring revenue base and medium-term revenue visibility.
🇦🇺 The Company’s Australian ownership, national footprint, and proven onshore delivery capability position it strongly for future government opportunities, particularly where sovereign capability and local supply chains are needed.
🚀 These contracts support AMX’s disciplined growth strategy, providing a platform to expand its government portfolio and deliver long-term shareholder value.

Aerometrex Chief Executive Officer Robert Veitch commented:
“We are proud to support Australian government agencies with high-quality, locally delivered solutions. These contract awards validate our strategy and strengthen our recurring revenue base. With a robust pipeline of opportunities across multiple departments, we see significant potential to expand our government portfolio in the years ahead.”